View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 3, 2020

Sysmex receives marketing approval for Malaria diagnostic device

Sysmex has received marketing approval for its Automated Hematology Analyzer XN-31 for use in the diagnosis of malaria in Japan.

Sysmex has received marketing approval for its Automated Hematology Analyzer XN-31 for use in the diagnosis of malaria in Japan.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

It is the first medical device for in vitro diagnosis to have been approved in Japan as a specially controlled medical device for use in the diagnosis of malaria (Class III).

The approval allows the device to be used for clinical applications as a measure against imported infectious diseases in Japan.

Automated Hematology Analyzer XN-31 is developed to help in the diagnosis of malaria by enabling qualitative analyses of formed elements in whole blood based on the count of DNA-containing malaria-infected RBCs (MI-RBCs).

The device uses electric impedance, light scattering by irradiating laser light onto cells that move inside a flow cell, or dye-binding for the analysis.

It counts, quantitated and identifies platelets, red blood cells and white blood cells. It also measures haemoglobin and determines hematocrit values, corpuscular constant, red blood cell distribution width and platelet distribution width.

Sysmex is planning to obtain marketing approval for the analyser in other countries in Asia and Africa.

Malaria is a protozoal disease, resulting from plasmodia transmitted by mosquitoes. It is considered to be one of the world’s three major infectious diseases.

Malarial parasites affect the circulating red blood cells (RBCs) in the body after a certain incubation period. High fever, headache, vomiting and anaemia are the symptoms associated with the diseases.

According to a report by the World Health Organization (WHO), at least 30,000 people get infected by malaria at their destinations every year and are diagnosed with the disease after returning home.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network